Has Karla Odell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,602 in general payments to Karla Odell, MD across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Karla Odell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Karla Odell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Karla Odell, MD

Otolaryngology · Los Angeles, CANPI 1861733602

Payments from drug & device makers

$2,602in general payments, 2019–2025

Across 13 payments — averaging $200.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$2K
Musculoskeletal Transplant Foundation Inc.$414
Olympus America Inc.$231
Acclarent, Inc$162
Steris Corporation$75
Optinose US, Inc.$59
plus $27 from 1 others

What the payments were for

Consulting fees$1,63563%
Food & beverage$96737%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	1	$1,635
Musculoskeletal Transplant Foundation Inc.	2	$414
Olympus America Inc.	2	$231
Acclarent, Inc	3	$162
Steris Corporation	1	$75
Optinose US, Inc.	3	$59
Medtronic	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,602 in reported general payments places this provider in the 70th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California →

Medicare billing

Part B allowed, 2024

$233,371

Medicare patients

394

Services billed

1,524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Qvar RedihalerBeclomethasone Dipropionate	16	$4,377
Ipratropium Bromide	35	$1,751
Pantoprazole Sodium	20	$227
Fluconazole	13	$196
Fluticasone Propionate	16	$136
Tramadol Hcl	28	$134
Montelukast Sodium	18	$108
Prednisone	19	$55

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Los Angeles

Keith BlackwellLos Angeles$349K
Martin HoppLos Angeles$321K
Arthur WuLos Angeles$279K
Dennis TangLos Angeles$261K
Jeffrey SuhLos Angeles$228K
Kevin ChoiLos Angeles$190K
Elisabeth FerenceLos Angeles$124K
Gene LiuLos Angeles$84K
Robert KangLos Angeles$57K
Richard MichelinLos Angeles$57K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →